Postpartum hemorrhage (PPH) is often defined as the loss of more than 500 ml or 1,000 ml of blood within the first 24 hours following childbirth.
This report contains market size and forecasts of Postpartum Bleeding Drug in global, including the following market information:
Global Postpartum Bleeding Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Postpartum Bleeding Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Postpartum Bleeding Drug companies in 2021 (%)
The global Postpartum Bleeding Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Postpartum Bleeding Drug include Merck, Pfizer, Novartis, Lupin Pharmaceuticals, Hikma Pharmaceuticals, Teva and Fresenius Kabi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Postpartum Bleeding Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Postpartum Bleeding Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postpartum Bleeding Drug Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Postpartum Bleeding Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postpartum Bleeding Drug Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Other
Global Postpartum Bleeding Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Postpartum Bleeding Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Postpartum Bleeding Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Postpartum Bleeding Drug revenues share in global market, 2021 (%)
Key companies Postpartum Bleeding Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Postpartum Bleeding Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Pfizer
Novartis
Lupin Pharmaceuticals
Hikma Pharmaceuticals
Teva
Fresenius Kabi